batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Exelixis abandons a synthetic lethality shot 19 May 2025 The first line swings it for Zynyz 16 May 2025 Keytruda hits the right notes in ovarian cancer 15 May 2025 Oncology is back for siRNA, courtesy of AbbVie 15 May 2025 Legend stakes its in vivo Car-T claim 14 May 2025 BeiGene remains bold with sonrotoclax 14 May 2025 BioNTech adds two conjugates to its immunotherapy effort 12 May 2025 Iovance and the Amtagvi poisoned chalice 12 May 2025 Load More